H-1 AND H-2 HISTAMINE-RECEPTORS IN N-NITROSO-N-METHYLUREA (NMU)-INDUCED CARCINOMAS WITH ATYPICAL COUPLING TO SIGNAL TRANSDUCERS

被引:79
作者
DAVIO, CA [1 ]
CRICCO, GP [1 ]
BERGOC, RM [1 ]
RIVERA, ES [1 ]
机构
[1] UNIV BUENOS AIRES,FAC FARM & BIOQUIM,CATEDRA FIS,RADIOISOTOPOS LAB,RA-1113 BUENOS AIRES,DF,ARGENTINA
关键词
HISTAMINE RECEPTORS; SIGNAL TRANSDUCTION; NMU-INDUCED CARCINOMAS;
D O I
10.1016/0006-2952(95)00108-C
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two specific binding sites for histamine were characterized in the cell membrane of N-nitroso-N-methylurea (NMU)-induced tumors. The first one, with higher affinity (K-d = 4 +/- 2 nM), was further identified as an H-2 type, while the lower affinity one (35 +/- 10 nM) corresponded to an H-1 receptor. Histamine concentrations up to 50 nM, as well as H-2 agonists, significantly enhanced the phosphoinositide turnover by acting through higher affinity H-2 receptors. On the other hand, histamine at concentrations over 50 nM and H-1 agonists produced a 100% increase in cAMP levels in a response specifically blocked by mepyramine. These H-1 and H-2 histamine receptors that exhibit different linkages to second messenger systems may prove to be a characteristic of cells with a high proliferating capacity, such as undifferentiated or transformed cells.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 30 条
[1]  
BARTHOLEYNS J, 1985, TRENDS PHARMACOL SCI, V16, P123
[2]  
BLACKMORE PF, 1992, ONCOGENE, V7, P2053
[3]  
CHOCHUNG YS, 1990, CANCER RES, V50, P7093
[4]   HISTAMINE AS AN AUTOCRINE GROWTH-FACTOR IN EXPERIMENTAL MAMMARY CARCINOMAS [J].
CRICCO, GP ;
DAVIO, CA ;
MARTIN, G ;
ENGEL, N ;
FITZSIMONS, CP ;
BERGOC, RM ;
RIVERA, ES .
AGENTS AND ACTIONS, 1994, 43 (1-2) :17-20
[5]  
CRICCO GP, 1993, AGENTS ACTIONS, V38, P175
[6]  
DAVIO C, 1994, AGENTS ACTIONS, V41, P115
[7]  
DAVIO CA, 1993, AGENTS ACTIONS, V38, P172
[8]   SPECIFIC BINDING OF H-3 TIOTIDINE TO HISTAMINE H-2 RECEPTORS IN GUINEA-PIG CEREBRAL-CORTEX [J].
GAJTKOWSKI, GA ;
NORRIS, DB ;
RISING, TJ ;
WOOD, TP .
NATURE, 1983, 304 (5921) :65-67
[9]  
GARBARG M, 1988, MOL PHARMACOL, V33, P38